Pentomone
This is an old revision of this page, as edited by JJMC89 bot III (talk | contribs) at 17:04, 16 July 2021 (Moving Category:Heterocyclic compounds (5 rings) to Category:Heterocyclic compounds with 5 rings per Wikipedia:Categories for discussion/Log/2021 June 24#Category:Heterocyclic compounds (1 ring)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
Other names | Lilly 113935; LY-113935 |
Drug class | Nonsteroidal antiandrogen |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C24H26O5 |
Molar mass | 394.467 g·mol−1 |
3D model (JSmol) | |
| |
|
Pentomone (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name) (developmental code name Lilly 113935 or LY-113935) is a nonsteroidal antiandrogen (NSAA) described as a "prostate growth inhibitor" which was never marketed.[1] It was synthesized and assayed in 1978.[1]
References
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 949–. ISBN 978-1-4757-2085-3.
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |